Acasti Pharma Year End Results

May 31, 2011 |

1 min read

LAVAL, Quebec, May 30, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, today reports its consolidated financial results for the fiscal year ended February 28, 2011.

Earnings

MORE ON THIS TOPIC

Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.

Series B

Nuclidium Nets $99M Series B for Copper-Based Radiopharma Platform

July 10, 2025

·

2 min read

·

Tristan Manalac

A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.

Gene therapy

AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M

July 9, 2025

·

1 min read

·

Dan Samorodnitsky

Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency

M&A

Merck Makes Big Respiratory Play With $10B Acquisition of Verona

July 9, 2025

·

2 min read

·

Tristan Manalac

Podcast

Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More

July 9, 2025

·

1 min read

·

Heather McKenzie